Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros




Base de datos
Intervalo de año de publicación
1.
Nucleic Acids Res ; 35(3): 801-11, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17202157

RESUMEN

Active promoters generally contain histone H3/H4 hyperacetylation and tri-methylation at H3 lysine 4, whereas repressed promoters are associated with DNA methylation. Here we show that the repressed erythroid-specific carbonic anhydrase II (CAII) promoter has active histone modifications localized around the transcription start, while high levels of CpG methylation are present directly upstream from these active marks. Despite the presence of active histone modifications, the repressed promoter requires hormone-induced activation for efficient preinitiation complex assembly. Transient and positional changes in histone H3/H4 acetylation and local changes in nucleosome density are evident during activation, but the bipartite epigenetic code is stably maintained. Our results suggest that active histone modifications may prevent spreading of CpG methylation towards the promoter and show that repressive DNA methylation immediately adjacent to a promoter does not necessarily repress transcription.


Asunto(s)
Islas de CpG , Metilación de ADN , Silenciador del Gen , Histonas/metabolismo , Regiones Promotoras Genéticas , Acetilación , Animales , Anhidrasa Carbónica II/genética , Anhidrasa Carbónica II/metabolismo , Línea Celular , Células Precursoras Eritroides/metabolismo , Histonas/química , Nucleosomas/metabolismo , Factores de Transcripción/metabolismo , Transcripción Genética/efectos de los fármacos , Triyodotironina/farmacología
2.
EMBO J ; 21(6): 1389-97, 2002 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-11889044

RESUMEN

To assess the mechanisms of repression of the erythroid-specific carbonic anhydrase II (CAII) locus we used chromatin immunoprecipitation and show that an NCoR-histone deacetylase (HDAC)3 complex is recruited by the nuclear receptor v-ErbA to the intronic HS2 enhancer turning it into a potent silencer. Furthermore we demonstrate that efficient CAII silencing requires binding of a MeCP2-targeted HDAC-containing corepressor complex to the hypermethylated CpG-island at the promoter. Activation of transcription by either AZAdC or thyroid hormone results in loss of one of the two corepressor complexes. Thyroid hormone further replaces the enhancer-bound NCoR-corepressor complex by the TRAP220 coactivator. Treatment with the HDAC inhibitor trichostatin A (TSA) causes activation of CAII transcription and histone H3 and H4 hyperacetylation at the enhancer, apparently without affecting binding of the two corepressor complexes. Unexpectedly, histone H3 and H4 at the fully repressed promoter are already hyperacetylated despite the close apposition of the MeCP2-targeted HDAC complex. Acetylation of histone H4, but not H3, at the promoter is moderately increased following TSA treatment. Our data suggest that the hyperacetylated but repressed CAII promoter is (partially) remodeled and primed for activation in v-ErbA-transformed cells.


Asunto(s)
Anhidrasa Carbónica II/genética , Proteínas Cromosómicas no Histona , Islas de CpG , Proteínas de Unión al ADN/metabolismo , Regulación Enzimológica de la Expresión Génica , Histona Desacetilasas/metabolismo , Proteínas Nucleares/metabolismo , Proteínas Represoras/metabolismo , Activación Transcripcional , Acetilación , Línea Celular Transformada , Humanos , Proteína 2 de Unión a Metil-CpG , Co-Represor 1 de Receptor Nuclear , Proteínas Oncogénicas v-erbA/genética , Proteínas Oncogénicas v-erbA/metabolismo , Regiones Promotoras Genéticas , Unión Proteica , Triyodotironina/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA